MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaad.2005.10.026

Медицинская библиотека · Journal of the American Academy of Dermatology · 2006

Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?

Schiller Meinhard, Böhm Markus, Hensen Peter, Riemann Helge, Luger Thomas A, Nashan Dorothée

Клинический случайСтатьяМетаанализПеревод в очереди

Аннотация

BACKGROUND

Dermatomyositis (DM) is an inflammatory connective tissue disorder well recognized as a paraneoplastic syndrome in adults.

OBJECTIVE

The objective of this study was to assess the prognosis of DM associated with malignant melanoma (MM).

PATIENTS AND

METHODS

We systematically searched databases (PubMed, MEDLINE, and WEB OF SCIENCE) for articles reporting the concurrence of DM and MM. For the literature study, time of onset of DM in relation to diagnosis of MM (before, concomitant with, or after), stage of MM after restaging (according to the American Joint Committee on Cancer [AJCC] guidelines, 2001), and survival time after diagnosis of DM were recorded. Survival time studies and univariate statistical analyses were performed. Furthermore, we present our own clinical case of a patient with DM concomitantly occurring with regional lymph node metastasis of MM.

RESULTS

In 5 cases DM occurred before, in 6 cases concomitantly with, and in 6 cases after progression of MM. Univariate analysis identified the AJCC stage of MM as a significant prognostic factor. Gender, age, and the time interval between onset of DM and progression of melanoma were unrelated. The 1-year actuarial survival rate was 0% for patients with DM when occurring with MM at stage IV and 60% when occurring with MM at stage III (P < .05). The estimated mean survival time was 6.6 months for patients with MM stage IV and 57 months for stage III.

LIMITATIONS: The conclusions from this study are limited by the relatively small number of articles that reported the association of MM and DM.

CONCLUSION

DM occurring in patients with MM at stage IV is connected with an extremely poor prognosis, whereas the few reported patients with DM and MM at stage III, including our case, have a prognosis similar to stage III patients without DM.

Для цитирования: Schiller Meinhard, Böhm Markus, Hensen Peter, Riemann Helge, Luger Thomas A, Nashan Dorothée. Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?. Journal of the American Academy of Dermatology. 2006. DOI: 10.1016/j.jaad.2005.10.026.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.